Literature DB >> 17696420

Conformation-activity relationship of neuropeptide S and some structural mutants: helicity affects their interaction with the receptor.

Teodorico Tancredi1, Remo Guerrini, Erika Marzola, Claudio Trapella, Girolamo Calo, Domenico Regoli, Rainer K Reinscheid, Valeria Camarda, Severo Salvadori, Piero Andrea Temussi.   

Abstract

Neuropeptide S (NPS) is the endogenous ligand of the previously orphan G-protein coupled receptor now named NPSR. The NPS-NPSR receptor system regulates important biological functions such as sleep/waking, locomotion, anxiety and food intake. Recently, exhaustive Ala scan and d-amino acid scan studies, together with systematic N- and C-terminal truncation, led to the identification of key residues for biological activity. Because conformational preferences might also play an important role, we undertook a detailed conformational analysis of NPS and several analogues in solution. We show that helicity induced by substitution of three flexible residues in the 5-13 regulatory region abolishes biological activity. A parallel pharmacological and conformational study of single and multiple substitutions of glycines 5, 7, and 9 showed that helicity can be tolerated in the C-terminal part of the peptide but not around Gly7. The identification of hNPSR partial agonists heralds the possibility of designing pure NPS receptor antagonists.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17696420     DOI: 10.1021/jm0706822

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

1.  Hypothalamic neuropeptide S receptor blockade decreases discriminative cue-induced reinstatement of cocaine seeking in the rat.

Authors:  Marsida Kallupi; Giordano de Guglielmo; Nazzareno Cannella; Hong Wu Li; Girolamo Caló; Remo Guerrini; Massimo Ubaldi; John J Renger; Victor N Uebele; Roberto Ciccocioppo
Journal:  Psychopharmacology (Berl)       Date:  2012-11-13       Impact factor: 4.530

2.  Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists.

Authors:  Remo Guerrini; Valeria Camarda; Claudio Trapella; Girolamo Caló; Anna Rizzi; Chiara Ruzza; Stella Fiorini; Erika Marzola; Rainer K Reinscheid; Domenico Regoli; Severo Salvadori
Journal:  J Med Chem       Date:  2009-07-09       Impact factor: 7.446

3.  In vitro and in vivo pharmacological characterization of the neuropeptide s receptor antagonist [D-Cys(tBu)5]neuropeptide S.

Authors:  Valeria Camarda; Anna Rizzi; Chiara Ruzza; Silvia Zucchini; Giuliano Marzola; Erika Marzola; Remo Guerrini; Severo Salvadori; Rainer K Reinscheid; Domenico Regoli; Girolamo Calò
Journal:  J Pharmacol Exp Ther       Date:  2008-10-29       Impact factor: 4.030

4.  Synthesis and biological activity of human neuropeptide S analogues modified in position 5: identification of potent and pure neuropeptide S receptor antagonists.

Authors:  Remo Guerrini; Valeria Camarda; Claudio Trapella; Girolamo Calò; Anna Rizzi; Chiara Ruzza; Stella Fiorini; Erika Marzola; Rainer K Reinscheid; Domenico Regoli; Severo Salvadori
Journal:  J Med Chem       Date:  2009-01-22       Impact factor: 7.446

5.  Identifying structural features on 1,1-diphenyl-hexahydro-oxazolo[3,4-a]pyrazin-3-ones critical for Neuropeptide S antagonist activity.

Authors:  Yanan Zhang; Brian P Gilmour; Hernán A Navarro; Scott P Runyon
Journal:  Bioorg Med Chem Lett       Date:  2008-06-12       Impact factor: 2.823

6.  Neuropeptide S-mediated facilitation of synaptic transmission enforces subthreshold theta oscillations within the lateral amygdala.

Authors:  Susanne Meis; Oliver Stork; Thomas Munsch
Journal:  PLoS One       Date:  2011-03-18       Impact factor: 3.240

7.  Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies.

Authors:  Chiara Ruzza; Federica Ferrari; Remo Guerrini; Erika Marzola; Delia Preti; Rainer K Reinscheid; Girolamo Calo
Journal:  Pharmacol Res Perspect       Date:  2018-12-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.